Pakistan's security forces killed at least 15 terrorists linked to the Tehreek-e-Taliban Pakistan (TTP) and the Balochistan Liberation Army (BLA) in two separate intelligence-based operations in ...

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 Earnings Call Transcript March 5, 2026 REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.3 EPS, expectations were $-1.01. Operator: Thank you for ...

Securities fraud class action lawsuit filed -- Class Period: September 24, 2025, and October 31, 2025 -- Deadline to Seek Lead Plaintiff Status: April 13, 2026 -- Key Lawsuit Allegations: Material ...

When most people are chasing dividends and safety, they often go for defensive stocks like consumer staples. However, ...

The FDA is expected to decide on treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, ...

Savara Inc. (the “Company”) (Nasdaq: SVRA ), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has received the Day 74 L ...

It started by tearing out Buddy’s dog pen, which was right outside our kitchen door. We had to put Buddy to sleep. Walking out the kitchen door and seeing his vacant pen was too much of a reminder of ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today provided an update ...

Imlifidase is a Streptococcus pyogenes-derived cysteine protease that rapidly degrades immunoglobulin G antibodies within 2 to 6 hours of administration.

A shareholder class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE). The ...

While the FDA appears to be adamant that uniQure conduct a sham surgery–controlled Phase 3 trial before AMT-130 can be ...